Source:http://linkedlifedata.com/resource/pubmed/id/19491670
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-8-13
|
pubmed:abstractText |
The role of a patent foramen ovale (PFO) as a risk factor for ischemic stroke has been established in recent years. However, the best therapeutic option to prevent recurrent events is still controversial, with antithrombotic treatment or transcatheter PFO closure being favored by different clinicians. Also, associated conditions that may guide the therapeutic choices are being investigated.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1531-7048
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
391-6
|
pubmed:dateRevised |
2011-9-26
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Patent foramen ovale and stroke: what should be done?
|
pubmed:affiliation |
Division of Cardiology, Columbia University, College of Physicians & Surgeons, New York, NY 10032, USA. md42@columbia.edu
|
pubmed:publicationType |
Journal Article,
Review
|